Table 4.
ECC Diagnosis (row %) | |||||
---|---|---|---|---|---|
| |||||
Total | < CIN2+ | CIN2+ | P-value | ||
Overall | 141 | 122 (86.5) | 19 (13.5) | ||
| |||||
ASC-US or LSIL | 88 | 82 (93.2) | 6 (6.8) | <0.05 | |
Cervical Cytology | ASC-H or HSIL+ | 48 | 36 (75.0) | 12 (25.0) | |
NA | 4 | 3 (75.0) | 1 (25.0) | ||
| |||||
HPV 16 Negative | 109 | 96 (88.1) | 13 (11.9) | 0.22 | |
HPV 16 Status | HPV 16 Positive | 31 | 25 (80.6) | 6 (19.4) | |
NA | 1 | 1 (100.0) | 0 (0.0) | ||
| |||||
Complete | 94 | 84 (89.4) | 10 (10.6) | 0.13 | |
% SCJ Visualized | Partial or not visualized | 45 | 36 (80.0) | 9 (20.0) | |
NA | 2 | 2 (100) | 0 (0.0) | ||
| |||||
< High-grade | 93 | 85 (91.4) | 8 (8.6) | < 0.05 | |
Colposcopic Impression | High-grade | 46 | 35 (76.1) | 11 (23.9) | |
NA | 2 | 2 (100) | 0 (0.0) |
ASC-US: Atypical squamous cells of undetermined significance; LSIL: Low-grade squamous intraepithelial lesion; ASC-H: atypical squamous cells, favor high-grade; HSIL: High-grade squamous intraepithelial lesion; AGC = atypical glandular cells; AIS = adenocarcinoma in situ; SCC = squamous cell carcinoma. HSIL+ includes HSIL, AGC, and SCC cytology. HPV: Human papillomavirus. SCJ: Squamo-columnar junction.